查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
CRISPR 和 cas 基因市場規模、市場份額、應用分析、區域展望、增長趨勢、主要參與者、競爭戰略和預測，2023-2031 年
市場調查報告書
商品編碼
1283944

CRISPR 和 cas 基因市場規模、市場份額、應用分析、區域展望、增長趨勢、主要參與者、競爭戰略和預測，2023-2031 年

CRISPR And Cas Genes Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 To 2031
出版日期: | 出版商: Acute Market Reports | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

CRISPR 和 cas 基因簇已成為基因工程領域最有前途的工具之一，徹底改變了我們處理基因編輯和工程的方式。CRISPR/Cas 系統是細菌中一種天然存在的機制，使它們能夠抵禦入侵的病毒。該系統可以靶向和改變特定基因，使其成為研究和醫學中的強大工具。全球 CRISPR 和 cas 基因簇市場預計在未來幾年將顯著增長，在 2023-2031 年的預測期內達到 18.5% 的複合年增長率。這種增長是由於農業、製藥和生物技術等各種應用對基因編輯技術的需求不斷增加。製藥和生物技術行業對 CRISPR 和 cas 基因簇市場的增長做出了重大貢獻。該技術有望治療多種遺傳疾病，並被用於藥物發現和藥物開發。農業也利用這項技術來提高作物產量和開發抗病作物。

製藥行業對基因編輯技術的需求不斷增長

製藥行業是 CRISPR 和 cas 基因簇市場的主要驅動力。該技術有可能治療多種遺傳疾病，並被用於藥物發現和藥物開發。到2025年，全球基因編輯市場預計將達到95億美元，而CRISPR/Cas系統是應用最廣泛的基因編輯技術。包括 CRISPR Therapeutics AG、Intellia Therapeutics 和 Editas Medicine 在內的幾家公司正在大力投資開發基於 CRISPR 的療法。

在農業中採用 CRISPR/Cas 技術

農業部門也在推動 CRISPR 和 cas 基因簇市場的增長。該技術用於提高作物產量和開發抗病作物。到 2025 年，全球農業生物技術市場預計將超過 550 億美元，而 CRISPR/Cas 系統是推動這一增長的關鍵技術之一。拜耳公司、杜邦先鋒和陶氏杜邦等公司正在大力投資開發 CRISPR 編輯作物。

遺傳病患病率上升

遺傳性疾病患病率上升推動了對 CRISPR 和 cas 基因簇等基因編輯技術的需求。根據世界衛生組織 (WHO) 的數據，遺傳病影響著全世界數百萬人，估計每 20 個新生兒中就有 1 個患有遺傳病。我在這裡。CRISPR/Cas 系統具有治療各種遺傳疾病的潛力，例如鐮狀細胞性貧血、囊性纖維化和亨廷頓舞蹈病。多項臨床試驗正在進行中，以驗證基於 CRISPR 的遺傳病療法的安全性和有效性，這可能會進一步推動 CRISPR 和 cas 基因簇市場的增長。

脫靶效應和倫理問題

CRISPR 和 cas 基因簇市場的主要製約因素之一是可能會導致意外和有害的基因組改變的脫靶效應。CRISPR/Cas 系統非常精確，但並不完美，脫靶效應的風險仍然存在。出於這個原因，人們擔心使用這種技術進行基因編輯的安全性和倫理影響。此外，有人擔心該技術可能會被濫用於非醫療目的，例如增強人類特徵。這些擔憂可能會導致監管審查力度加大和技術採用速度放緩，從而抑制 CRISPR 和 cas 基因簇市場的增長。

生物醫藥板塊主導市場銷售

CRISPR 和 cas 基因簇市場有望在生物醫學和農業領域實現顯著增長。就收入而言，由於藥物發現和市場開發對基因編輯技術的高需求，生物醫藥板塊預計將主導市場。2022年，生物醫學板塊將佔據CRISPR和cas基因簇市場的最大份額，預計該板塊在2023-2031年的預測期內也將主導市場。另一方面，由於對抗病和高產作物的需求不斷增長，預計農業部門在預測期內的複合年增長率最高。CRISPR/Cas 系統用於開發具有理想性狀的作物，例如增加產量、耐旱性和抗病性。包括Bayer AG和DowDuPont在內的幾家公司已投入巨資開發 CRISPR 編輯的作物，這可能會進一步推動農業部門的增長。

生物技術和製藥公司主導市場收入

CRISPR 和 cas 基因簇市場也按最終用途細分，包括生物技術和製藥公司、學術和政府研究機構以及合同研究組織 (CRO)。由於藥物發現和藥物開發對基因編輯技術的高需求，預計生物技術和製藥公司將在收入方面佔據市場主導地位。到 2022 年，生物技術和製藥公司將佔據 CRISPR 和 cas 基因簇市場的最大份額。然而，由於生物技術和製藥公司越來越多地外包臨床前和臨床研究活動，預計合同研究組織 (CRO) 部分在 2023 年至 2031 年的預測期內將實現最高複合年增長率。CRO 提供廣泛的服務，包括藥物發現和開發、臨床試驗和監管服務。CRISPR 和 cas 基因簇在臨床前和臨床研究活動中的使用有望增加，這可能會進一步推動 CRO 領域的發展。

北美仍然是世界領先者

由於該地區有幾個主要參與者以及生物技術和製藥行業對基因編輯技術的採用率很高，北美將在 2022 年佔據最大的市場份額。然而，由於該地區對生物技術研究的投資不斷增加以及遺傳疾病的流行率不斷上升，預計亞太地區的複合年增長率將最高。此外，該地區還有幾家新興的生物技術和製藥公司，這可能會進一步推動市場增長。由於政府對基因組編輯研究的資助增加以及對轉基因作物的需求增加，預計歐洲也將為市場的增長做出重大貢獻。

預測期內市場競爭加劇

CRISPR 和 cas 基因簇市場競爭激烈，市場上有多家主要參與者。市場領導者包括 Thermo Fisher Scientific, Inc.、Editas Medicine, Inc.、CRISPR Therapeutics AG、Intellia Therapeutics, Inc. 和 Caribou Biosciences, Inc.。這些參與者正專注於戰略合作、合作夥伴關係和併購，以擴大他們的市場影響力並加強他們的產品組合。例如，2020 年，Thermo Fisher Scientific 收購了領先的分子診斷和樣品製備技術提供商 QIAGEN NV，以擴大其生命科學產品範圍。Editas Medicine 還與生物技術和製藥行業的主要參與者建立了多項合作夥伴關係，以推進 CRISPR 基因編輯技術。此外，一些主要參與者正在投資研發活動，以開發新的和創新的基因編輯技術。例如，CRISPR Therapeutics 正在開發針對多種遺傳疾病的基於 CRISPR 的療法組合，而 Intellia Therapeutics 正在開髮用於體內遞送 CRISPR-Cas9 基因編輯技術的專有平台。。此外，這些公司正專注於為其基因編輯技術獲得監管批准。例如，2019 年，CRISPR Therapeutics 和 Vertex Pharmaceuticals 獲得 FDA 批准使用 CRISPR-Cas9 技術進行基因療法治療鐮狀細胞病。

目錄

第一章 前言

  • 舉報內容
    • 報告目的
    • 目標聽眾
    • 提供的主要產品
  • 市場細分
  • 調查方法
    • 第一階段 - 二次調查
    • 第二階段 - 初步調查
    • 第三階段——專家評審
    • 先決條件
    • 採取的方法

第二章執行摘要

第三章 CRISPR 和 cas 基因市場：競爭分析

  • 主要廠商的市場定位
  • 供應商採用的策略
  • 重點產業戰略
  • 等級分析：2022 年與 2031 年

第 4 章 CRISPR 和 cas 基因市場：宏觀分析和市場動態

  • 介紹
  • CRISPR 和 cas 基因簇的全球市場價值 2021-2031
  • 市場動態
    • 市場驅動力
    • 市場製約因素
    • 主要問題
    • 主要機會
  • 促進因素和抑制因素的影響分析
  • 蹺蹺板分析

5. 2021-2031 年按產品分列的 CRISPR 和 cas 基因市場

  • 市場概況
  • 增長/利潤分析：2022 年與 2031 年
  • 市場細分
    • 試劑盒和酶
      • 基於向量的 Cas
      • 無 DNA Ca
    • 圖書館
    • 設計工具
    • 抗體
    • 其他

6. 2021-2031 年按服務分列的 CRISPR 和 cas 基因市場

  • 市場概況
  • 增長/利潤分析：2022 年與 2031 年
  • 市場細分
    • 細胞系工程
    • gRNA 的設計
    • 微生物基因編輯
    • DNA合成

7. 2021-2031 年按應用分列的 CRISPR 和 cas 基因市場

  • 市場概況
  • 增長/利潤分析：2022 年與 2031 年
  • 市場細分
    • 生物醫學
      • 基因組工程
      • 疾病模型研究
      • 功能基因組學
      • 表觀遺傳學
      • 其他
    • 農業

8. 2021-2031 年最終用途的 CRISPR 和 cas 基因市場

  • 市場概況
  • 增長/利潤分析：2022 年與 2031 年
  • 市場細分
    • 生物技術和製藥公司
    • 學術機構和政府研究機構
    • 合同研究組織 (CRO)

第 9 章北美 CRISPR 和 cas 基因簇市場 2021-2031

  • 市場概況
  • 2021-2031 年各產品的 CRISPR 和 cas 基因市場
  • 2021-2031 年各服務的 CRISPR 和 cas 基因市場
  • 2021-2031 年按應用分列的 CRISPR 和 cas 基因市場
  • 2021-2031 年最終用途的 CRISPR 和 cas 基因市場
  • CRISPR 和 cas 基因的區域市場 2021-2031
    • 北美
      • 美國
      • 加拿大
      • 其他北美

10.英國和歐盟CRISPR和cas基因簇市場2021-2031

  • 市場概況
  • 2021-2031 年各產品的 CRISPR 和 cas 基因市場
  • 按服務劃分的 CRISPR 和 cas 基因市場 2021-2031
  • 2021-2031 年按應用分列的 CRISPR 和 cas 基因市場
  • 2021-2031 年最終用途的 CRISPR 和 cas 基因市場
  • CRISPR 和 cas 基因的區域市場 2021-2031
    • 英國和歐盟
      • 英國
      • 德國
      • 西班牙
      • 意大利
      • 法國
      • 歐洲其他地區

第 11 章亞太 CRISPR 和 cas 基因簇市場 2021-2031

  • 市場概況
  • 2021-2031 年各產品的 CRISPR 和 cas 基因市場
  • 按服務劃分的 CRISPR 和 cas 基因市場 2021-2031
  • 2021-2031 年按應用分列的 CRISPR 和 cas 基因市場
  • 2021-2031 年最終用途的 CRISPR 和 cas 基因市場
  • CRISPR 和 cas 基因的區域市場 2021-2031
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 亞太其他地區

第 12 章拉丁美洲 CRISPR 和 cas 基因簇市場 2021-2031

  • 市場概況
  • 2021-2031 年各產品的 CRISPR 和 cas 基因市場
  • 按服務劃分的 CRISPR 和 cas 基因市場 2021-2031
  • 2021-2031 年按應用分列的 CRISPR 和 cas 基因市場
  • 2021-2031 年最終用途的 CRISPR 和 cas 基因市場
  • CRISPR 和 cas 基因的區域市場 2021-2031
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地區

13中東和非洲CRISPR和cas基因簇市場2021-2031

  • 市場概況
  • 2021-2031 年各產品的 CRISPR 和 cas 基因市場
  • 按服務劃分的 CRISPR 和 cas 基因市場 2021-2031
  • 2021-2031 年按應用分列的 CRISPR 和 cas 基因市場
  • 2021-2031 年最終用途的 CRISPR 和 cas 基因市場
  • CRISPR 和 cas 基因的區域市場 2021-2031
    • 中東/非洲
      • GCC
      • 非洲
      • 其他中東/非洲地區

第十四章公司簡介

  • Thermo Fisher Scientific Inc.
  • Editas Medicine Inc.
  • CRISPR Therapeutics AG
  • Intellia Therapeutics Inc.
  • Caribou Biosciences Inc.
  • 其他
Product Code: 139592-05-23

CRISPR and Cas genes have become one of the most promising tools in the field of genetic engineering, revolutionizing the way we approach gene editing and genetic manipulation. The CRISPR/Cas system is a naturally occurring mechanism in bacteria that allows them to defend themselves against invading viruses. This system can be adapted to target and modify specific genes, making it a powerful tool in research and medicine. The global CRISPR and Cas genes market is expected to grow significantly in the coming years, with a CAGR of 18.5% during the forecast period of 2023 to 2031. This growth is driven by the increasing demand for gene editing technologies in various applications such as agriculture, pharmaceuticals, and biotechnology. The pharmaceutical and biotechnology industries are the major contributors to the growth of the CRISPR and Cas genes market. The technology is being used in drug discovery and development, with the potential to treat a wide range of genetic disorders. The agriculture industry is also adopting this technology to improve crop yields and develop disease-resistant crops.

Increasing Demand for Gene Editing Technologies in Pharmaceutical Industry

The pharmaceutical industry is a major driver of the CRISPR and Cas genes market. The technology is being used in drug discovery and development, with the potential to treat a wide range of genetic disorders. The global gene editing market is expected to reach $9.5 billion by 2025, with the CRISPR/Cas system being the most widely used gene editing technology. Several companies are investing heavily in the development of CRISPR-based therapies, including CRISPR Therapeutics AG, Intellia Therapeutics, and Editas Medicine, among others.

Adoption of CRISPR/Cas Technology in Agriculture

The agriculture industry is also driving the growth of the CRISPR and Cas genes market. The technology is being used to improve crop yields and develop disease-resistant crops. The global agricultural biotechnology market is expected to cross $55 billion by 2025, with the CRISPR/Cas system being one of the key technologies driving this growth. Companies such as Bayer AG, DuPont Pioneer, and DowDuPont are investing heavily in the development of CRISPR-edited crops.

Rising Prevalence of Genetic Disorders

The rising prevalence of genetic disorders is driving the demand for gene editing technologies such as CRISPR and Cas genes. According to the World Health Organization, genetic disorders affect millions of people worldwide, with an estimated 1 in 20 live births being affected by a genetic disorder. The CRISPR/Cas system has the potential to treat a wide range of genetic disorders, including sickle cell anemia, cystic fibrosis, and Huntington's disease, among others. Several clinical trials are underway to test the safety and efficacy of CRISPR-based therapies for genetic disorders, which could further drive the growth of the CRISPR and Cas genes market.

Off-Target Effects and Ethical Concerns

One of the major restraints of the CRISPR and Cas genes market is the potential for off-target effects, which can result in unintended and potentially harmful changes to the genome. While the CRISPR/Cas system is highly precise, it is not perfect, and there is still a risk of off-target effects. This has led to concerns about the safety and ethical implications of using this technology for gene editing. In addition, there are also concerns about the potential misuse of this technology for non-medical purposes, such as enhancing human traits. These concerns could lead to increased regulatory scrutiny and slower adoption of the technology, which could restrain the growth of the CRISPR and Cas genes market.

Biomedical Segment to Dominate the Market Revenues

The CRISPR and Cas genes market is expected to witness significant growth in both the biomedical and agriculture segments. In terms of revenue, the biomedical segment is expected to dominate the market due to the high demand for gene editing technologies in drug discovery and development. The biomedical segment accounted for the largest share of the CRISPR and Cas genes market in 2022, the segment is also expected to dominate the market during the forecast period of 2023 to 2031. On the other hand, the agriculture segment is expected to witness the highest CAGR during the forecast period, driven by the increasing demand for disease-resistant and high-yielding crops. The CRISPR/Cas system is being used to develop crops with desirable traits, such as increased yield, drought resistance, and disease resistance. Several companies, including Bayer AG and DowDuPont, are investing heavily in the development of CRISPR-edited crops, which could further drive the growth of the agriculture segment.

Biotechnology and Pharmaceutical Companies to Dominate the Market Revenues

The CRISPR and Cas genes market is also segmented by end-use, including biotechnology and pharmaceutical companies, academics and government research institutes, and contract research organizations (CROs). Biotechnology and pharmaceutical companies are expected to dominate the market in terms of revenue, owing to the high demand for gene editing technologies in drug discovery and development. The biotechnology and pharmaceutical companies segment accounted for the largest share of the CRISPR and Cas genes market in 2022. However, the highest CAGR during the forecast period of 2023 to 2031 is expected in the contract research organizations (CROs) segment, driven by the increasing outsourcing of preclinical and clinical research activities by biotechnology and pharmaceutical companies. CROs provide a wide range of services, including drug discovery and development, clinical trials, and regulatory services, among others. The use of CRISPR and Cas genes in preclinical and clinical research activities is expected to increase, which could further drive the growth of the CROs segment.

North America Remains as the Global Leader

North America accounted for the largest share of the market in 2022, owing to the presence of several key players in the region and the high adoption rate of gene editing technologies in the biotechnology and pharmaceutical industries. However, the highest CAGR is expected in the Asia-Pacific region, driven by the increasing investments in biotechnology research and the growing prevalence of genetic disorders in the region. The region is also home to several emerging biotechnology and pharmaceutical companies, which could further drive the growth of the market. Europe is also expected to contribute significantly to the growth of the CRISPR and Cas genes market, owing to the increasing government funding for genome editing research and the growing demand for genetically modified crops in the region.

Market Competition to Intensify during the Forecast Period

The CRISPR and Cas genes market is highly competitive, with several key players operating in the market. Some of the top players in the market include Thermo Fisher Scientific, Inc., Editas Medicine, Inc., CRISPR Therapeutics AG, Intellia Therapeutics, Inc., and Caribou Biosciences, Inc., among others. These players are focusing on strategic collaborations, partnerships, and mergers and acquisitions to expand their market presence and strengthen their product portfolios. For instance, in 2020, Thermo Fisher Scientific acquired QIAGEN N.V., a leading provider of molecular diagnostics and sample preparation technologies, to expand its life sciences offerings. In addition, Editas Medicine has entered into several collaborations with key players in the biotechnology and pharmaceutical industries to advance its CRISPR gene editing technology. Furthermore, several key players are investing in research and development activities to develop new and innovative gene editing technologies. For instance, CRISPR Therapeutics is developing a portfolio of CRISPR-based therapies for a wide range of genetic disorders, while Intellia Therapeutics is developing a proprietary platform for the in vivo delivery of CRISPR-Cas9 gene editing technology. Moreover, companies are also focusing on obtaining regulatory approvals for their gene editing technologies. For instance, in 2019, CRISPR Therapeutics and Vertex Pharmaceuticals received FDA approval for their gene therapy, which uses CRISPR-Cas9 technology to treat sickle cell disease.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of CRISPR And Cas Genes market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the CRISPR And Cas Genes market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • Kits & Enzymes
    • Vector-based Cas
    • DNA-free Cas
  • Libraries
  • Design Tool
  • Antibodies
  • Others

Service

  • Cell Line Engineering
  • gRNA Design
  • Microbial Gene Editing
  • DNA Synthesis

Application

  • Biomedical
    • Genome Engineering
    • Disease Model Studies
    • Functional Genomics
    • Epigenetics
    • Others
  • Agricultural

End-use

  • Biotechnology & Pharmaceutical Companies
  • Academics & Government Research Institutes
  • Contract Research Organizations (CROs)

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of CRISPR And Cas Genes market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the CRISPR And Cas Genes market?
  • Which is the largest regional market for CRISPR And Cas Genes market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving CRISPR And Cas Genes market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the CRISPR And Cas Genes market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global CRISPR And Cas Genes Market
  • 2.2. Global CRISPR And Cas Genes Market, By Product, 2022 (US$ Million)
  • 2.3. Global CRISPR And Cas Genes Market, By Service, 2022 (US$ Million)
  • 2.4. Global CRISPR And Cas Genes Market, By Application, 2022 (US$ Million)
  • 2.5. Global CRISPR And Cas Genes Market, By End-use, 2022 (US$ Million)
  • 2.6. Global CRISPR And Cas Genes Market, By Geography, 2022 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2022

3. CRISPR And Cas Genes Market: Competitive Analysis

  • 3.1. Market Positioning of Key CRISPR And Cas Genes Market Vendors
  • 3.2. Strategies Adopted by CRISPR And Cas Genes Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. CRISPR And Cas Genes Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global CRISPR And Cas Genes Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Kits & Enzymes
      • 5.3.1.1. Vector-based Cas
      • 5.3.1.2. DNA-free Cas
    • 5.3.2. Libraries
    • 5.3.3. Design Tool
    • 5.3.4. Antibodies
    • 5.3.5. Others

6. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Cell Line Engineering
    • 6.3.2. gRNA Design
    • 6.3.3. Microbial Gene Editing
    • 6.3.4. DNA Synthesis

7. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Biomedical
      • 7.3.1.1. Genome Engineering
      • 7.3.1.2. Disease Model Studies
      • 7.3.1.3. Functional Genomics
      • 7.3.1.4. Epigenetics
      • 7.3.1.5. Others
    • 7.3.2. Agricultural

8. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 8.3. Market Segmentation
    • 8.3.1. Biotechnology & Pharmaceutical Companies
    • 8.3.2. Academics & Government Research Institutes
    • 8.3.3. Contract Research Organizations (CROs)

9. North America CRISPR And Cas Genes Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
  • 9.3. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
  • 9.4. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
  • 9.5. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
  • 9.6.CRISPR And Cas Genes Market: By Region, 2021-2031, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 9.6.1.1.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 9.6.1.1.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.1.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 9.6.1.2.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 9.6.1.2.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.2.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 9.6.1.3.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 9.6.1.3.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 9.6.1.3.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

10. UK and European Union CRISPR And Cas Genes Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
  • 10.3. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
  • 10.4. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
  • 10.5. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
  • 10.6.CRISPR And Cas Genes Market: By Region, 2021-2031, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.1.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.1.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.1.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.2.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.2.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.2.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.3.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.3.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.3.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.4.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.4.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.4.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.5.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.5.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.5.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 10.6.1.6.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 10.6.1.6.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 10.6.1.6.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

11. Asia Pacific CRISPR And Cas Genes Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
  • 11.3. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
  • 11.4. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
  • 11.5. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
  • 11.6.CRISPR And Cas Genes Market: By Region, 2021-2031, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.1.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.1.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.1.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.2.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.2.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.2.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.3.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.3.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.3.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.4.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.4.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.4.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.5.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.5.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.5.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 11.6.1.6.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 11.6.1.6.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 11.6.1.6.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

12. Latin America CRISPR And Cas Genes Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
  • 12.3. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
  • 12.4. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
  • 12.5. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
  • 12.6.CRISPR And Cas Genes Market: By Region, 2021-2031, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 12.6.1.1.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 12.6.1.1.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.1.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 12.6.1.2.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 12.6.1.2.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.2.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 12.6.1.3.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 12.6.1.3.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 12.6.1.3.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

13. Middle East and Africa CRISPR And Cas Genes Market, 2021-2031, USD (Million)

  • 13.1. Market Overview
  • 13.2. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
  • 13.3. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
  • 13.4. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
  • 13.5. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
  • 13.6.CRISPR And Cas Genes Market: By Region, 2021-2031, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 13.6.1.1.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 13.6.1.1.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.1.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 13.6.1.2.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 13.6.1.2.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.2.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. CRISPR And Cas Genes Market: By Product, 2021-2031, USD (Million)
        • 13.6.1.3.1. CRISPR And Cas Genes Market: By Service, 2021-2031, USD (Million)
        • 13.6.1.3.1. CRISPR And Cas Genes Market: By Application, 2021-2031, USD (Million)
        • 13.6.1.3.1. CRISPR And Cas Genes Market: By End-use, 2021-2031, USD (Million)

14. Company Profile

  • 14.1. Thermo Fisher Scientific, Inc.
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. Editas Medicine, Inc.
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. CRISPR Therapeutics AG
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Intellia Therapeutics, Inc.
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. Caribou Biosciences, Inc.
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Other Notable Players
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 2 Global CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 3 Global CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 4 Global CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 5 Global CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 6 Global CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 7 North America CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 8 North America CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 9 North America CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 10 North America CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 11 North America CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 12 North America CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 13 U.S. CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 14 U.S. CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 15 U.S. CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 16 U.S. CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 17 U.S. CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 18 U.S. CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 19 Canada CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 20 Canada CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 21 Canada CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 22 Canada CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 23 Canada CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 24 Canada CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 25 Rest of North America CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 26 Rest of North America CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 27 Rest of North America CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 28 Rest of North America CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 29 Rest of North America CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 30 Rest of North America CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 31 UK and European Union CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 32 UK and European Union CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 33 UK and European Union CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 34 UK and European Union CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 35 UK and European Union CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 36 UK and European Union CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 37 UK CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 38 UK CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 39 UK CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 40 UK CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 41 UK CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 42 UK CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 43 Germany CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 44 Germany CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 45 Germany CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 46 Germany CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 47 Germany CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 48 Germany CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 49 Spain CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 50 Spain CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 51 Spain CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 52 Spain CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 53 Spain CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 54 Spain CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 55 Italy CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 56 Italy CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 57 Italy CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 58 Italy CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 59 Italy CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 60 Italy CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 61 France CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 62 France CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 63 France CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 64 France CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 65 France CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 66 France CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 67 Rest of Europe CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 68 Rest of Europe CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 69 Rest of Europe CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 70 Rest of Europe CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 71 Rest of Europe CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 72 Rest of Europe CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 73 Asia CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 74 Asia CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 75 Asia CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 76 Asia CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 77 Asia CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 78 Asia CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 79 China CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 80 China CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 81 China CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 82 China CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 83 China CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 84 China CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 85 Japan CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 86 Japan CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 87 Japan CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 88 Japan CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 89 Japan CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 90 Japan CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 91 India CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 92 India CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 93 India CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 94 India CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 95 India CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 96 India CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 97 Australia CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 98 Australia CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 99 Australia CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 100 Australia CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 101 Australia CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 102 Australia CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 103 South Korea CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 104 South Korea CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 105 South Korea CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 106 South Korea CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 107 South Korea CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 108 South Korea CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 109 Latin America CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 110 Latin America CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 111 Latin America CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 112 Latin America CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 113 Latin America CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 114 Latin America CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 115 Brazil CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 116 Brazil CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 117 Brazil CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 118 Brazil CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 119 Brazil CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 120 Brazil CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 121 Mexico CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 122 Mexico CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 123 Mexico CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 124 Mexico CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 125 Mexico CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 126 Mexico CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 127 Rest of Latin America CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 128 Rest of Latin America CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 129 Rest of Latin America CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 130 Rest of Latin America CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 131 Rest of Latin America CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 132 Rest of Latin America CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 133 Middle East and Africa CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 134 Middle East and Africa CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 135 Middle East and Africa CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 136 Middle East and Africa CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 137 Middle East and Africa CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 138 Middle East and Africa CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 139 GCC CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 140 GCC CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 141 GCC CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 142 GCC CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 143 GCC CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 144 GCC CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 145 Africa CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 146 Africa CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 147 Africa CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 148 Africa CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 149 Africa CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 150 Africa CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)
  • TABLE 151 Rest of Middle East and Africa CRISPR And Cas Genes Market By Product, 2021-2031, USD (Million)
  • TABLE 152 Rest of Middle East and Africa CRISPR And Cas Genes Market By Kits & Enzymes, 2021-2031, USD (Million)
  • TABLE 153 Rest of Middle East and Africa CRISPR And Cas Genes Market By Service, 2021-2031, USD (Million)
  • TABLE 154 Rest of Middle East and Africa CRISPR And Cas Genes Market By Application, 2021-2031, USD (Million)
  • TABLE 155 Rest of Middle East and Africa CRISPR And Cas Genes Market By Biomedical, 2021-2031, USD (Million)
  • TABLE 156 Rest of Middle East and Africa CRISPR And Cas Genes Market By End-use, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global CRISPR And Cas Genes Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global CRISPR And Cas Genes Market: Quality Assurance
  • FIG. 5 Global CRISPR And Cas Genes Market, By Product, 2022
  • FIG. 6 Global CRISPR And Cas Genes Market, By Service, 2022
  • FIG. 7 Global CRISPR And Cas Genes Market, By Application, 2022
  • FIG. 8 Global CRISPR And Cas Genes Market, By End-use, 2022
  • FIG. 9 Global CRISPR And Cas Genes Market, By Geography, 2022
  • FIG. 10 Market Geographical Opportunity Matrix - Global CRISPR And Cas Genes Market, 2022
  • FIG. 11 Market Positioning of Key CRISPR And Cas Genes Market Players, 2022
  • FIG. 12 Global CRISPR And Cas Genes Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
  • FIG. 13 Global CRISPR And Cas Genes Market, By Product, 2022 Vs 2031, %
  • FIG. 14 Global CRISPR And Cas Genes Market, By Service, 2022 Vs 2031, %
  • FIG. 15 Global CRISPR And Cas Genes Market, By Application, 2022 Vs 2031, %
  • FIG. 16 Global CRISPR And Cas Genes Market, By End-use, 2022 Vs 2031, %
  • FIG. 17 U.S. CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 18 Canada CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 19 Rest of North America CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 20 UK CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 21 Germany CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 22 Spain CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 23 Italy CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 24 France CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 25 Rest of Europe CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 26 China CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 27 Japan CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 28 India CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 29 Australia CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 30 South Korea CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 31 Rest of Asia CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 32 Brazil CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 33 Mexico CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 34 Rest of Latin America CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 35 GCC CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 36 Africa CRISPR And Cas Genes Market (US$ Million), 2021 - 2031
  • FIG. 37 Rest of Middle East and Africa CRISPR And Cas Genes Market (US$ Million), 2021 - 2031